 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Procter & Gamble Health announced that the Annual General Meeting (AGM) of the company will be held on 21 November 2023.

Procter & Gamble Health to conduct AGM

Procter&amp;Gamble Standalone June 2023 Net Sales at Rs 301.18 crore, up 1.79% Y-o-Y

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 23 August 2023, inter alia, have recommended the final dividend of Rs 50 per equity Share (i.e. 500%) , subject to the approval of the shareholders.

 Board of Procter & Gamble Health recommends final dividend

The company said that the profit was impacted due to higher material cost and one-time employee cost.Revenue from operations rose marginally to Rs 301.18 crore during the quarter from Rs 295.89 crore posted in the same period a year ago. The sales grew at low single digit against the headwinds of slowing down of the category in the quarter.Profit before tax dropped 19.2% year on year to Rs 44.13 crore in the quarter ended 30 June 2023.Total expenses were at Rs 262.51 crore in Q4 June 2023, registering a growth of 7.44% on YoY basis. Cost of materials consumed stood at Rs 74.31 crore (up 2.54% YoY) while employee benefits expenses came in at Rs 55.40 crore (up 31.5% YoY) during the period under review.On full year basis, the companys net profit jumped 19.2% to Rs 229.47 crore on 10.3% rise in revenue to Rs 1,229.62 crore in FY23 over FY22.Milind Thatte, managing director, Procter & Gamble Health, “We continued our efforts towards brand and category development and thus delivered a strong performance in the fiscal, marked by consistent growth across all our brands. The quarter, however, witnessed a category slowdown across our portfolio. Despite these challenges, we continued our commitment to our strategy of five integrated choices: a portfolio of daily-use products where performance drives brand choice; superiority across product, package, brand communication, retail execution, and value; productivity; constructive disruption of the entire value chain; and a highly efficient and effective organization structure.”Meanwhile, the firms board has recommended a final dividend of Rs 50 per equity share, for the financial year ending 30 June 2023, subject to the approval of the shareholders.Procter & Gamble Health (P&G Health) is one of Indias largest VMS companies, manufacturing and marketing vitamins, minerals, and supplements products that include Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion.

P&G Health slides as Q4 PAT drops 28% YoY 

Procter&amp;Gamble Standalone March 2023 Net Sales at Rs 320.92 crore, up 19.83% Y-o-Y

Motilal Oswal recommended Neutral rating on Procter Gamble Hygiene Health Care with a target price of Rs15,050 in its research report dated May 10, 2023.

Neutral Procter Gamble Hygiene Health Care; target of Rs 15,050: Motilal Oswal

Procter&amp;Gamble Standalone December 2022 Net Sales at Rs 309.97 crore, up 11.54% Y-o-Y

Procter &amp; Gamble Health shares had a robust gap up opening on Monday, rising nearly 15 percent to Rs 4,703, the highest closing level since February 16, 2022. In fact, the gap up opening has helped the stock climb over all long term moving averages (50, 100 and 200 EMA). The stock has formed strong bullish candlestick pattern on the daily charts with healthy volumes.

Trade Spotlight | Your blueprint for Procter &amp; Gamble Health, M&amp;M Financial Services, Zydus Lifesciences today

Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. It offers its products through the following brands: Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. It operates through India, and Outside India geographical segments. The company was founded in 1967 and is headquartered in Mumbai, India.

Watchers	28
52-Wk Low	3,870.10
52-Wk High	5,500.00

Market Cap	83.92B
Volume (M)	22,143.00
52-Wk High	5,500.00
52-Wk Low	3,870.10

PGHL.NSE Procter & Gamble Health Ltd.

About

Feed

News

Fundamentals